Navigation Links
Raptor Pharmaceuticals Provides Update of Product Programs
Date:9/13/2007

these forward-looking statements. Factors which may significantly change or prevent the Company's forward looking statements from fruition include that the Company may be unsuccessful in developing any products; that its technology may not be validated as the Company progresses further and its methods may not be accepted by the scientific community; that the Company is unable to retain or attract key employees whose knowledge is essential to the development of its products; that unforeseen scientific difficulties develop with the Company's process; that the Company's patents are not sufficient to protect essential aspects of its technology; that competitors may invent better technology; that the Company's products may not work as well as hoped or worse, that the Company's products may harm recipients; and that the Company may not be able to raise sufficient funds for development or working capital when required. As well, the Company's products may never develop into useful products and even if they do, they may not be approved for sale to the public. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in the Company's filings from time to time with the Securities and Exchange Commission ("SEC"), which we strongly urge you to read and consider, including the Company's Registration Statement on Form SB-2, as amended, that was declared effective on July 10, 2006, the Company's annual report on Form 10- KSB and Form 10-KSB/A filed with the SEC on November 22, 2006, and January 18, 2007, respectively, and the Company's quarterly report Form 10-QSB filed with the SEC on June 29, 2007, all of which are available free of charge on the SEC's web site at http://www.sec.gov.

Subsequent written and oral forward-looking statements attributable to t
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... SAN FRANCISCO, Calif. , May 28, 2015 /PRNewswire/ ... treatment of cancer, today announced that Sean McCarthy ... the upcoming Jefferies 2015 Global Healthcare Conference ... p.m. EDT on Tuesday, June 2, 2015. Dr. McCarthy ... the company,s Precision cancer immunotherapy and Probody drug conjugate ...
(Date:5/28/2015)... 28, 2015  Shareholder rights law firm Robbins ... officers and directors of Eleven Biotherapeutics, Inc. (NASDAQGM: EBIO) ... is a clinical-stage biopharmaceutical company that engages in ... treat eye diseases, primarily in the ... this press release on the law firm,s Shareholder ...
(Date:5/28/2015)... Eli Lilly and Company (NYSE: LLY ) and Incyte ... June 11 to discuss data from the first two pivotal ... two trials, RA-BEACON and RA-BUILD, will be presented on June ... in Rome, Italy . The ... Time. The live audio webcast can be accessed through a ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3
... ... Clinical Duration, CAMBRIDGE, Mass., March 10 ... large, multicenter,observational study that investigated the long-term durability of,Carticel(R) (autologous cultured ... the articular cartilage of their,knee. These findings revealed that almost 90 ...
... The,Journal of the American College of Cardiology has ... Performance of PTCA in,Patients Without Documented Ischemia) as one ... in 2007, according to an article entitled,"Highlights of the ... al. (JACC,Vol. 51, No. 4, 2008 January 29, 2008:490-512), ...
Cached Medicine Technology:Genzyme Announces Presentation of New Positive Data on Carticel(R) 2Genzyme Announces Presentation of New Positive Data on Carticel(R) 3Genzyme Announces Presentation of New Positive Data on Carticel(R) 4Genzyme Announces Presentation of New Positive Data on Carticel(R) 5Genzyme Announces Presentation of New Positive Data on Carticel(R) 6JACC Identifies DEFER with 5-year Outcomes as Landmark Trial 2
(Date:5/28/2015)... AMVETS leaders this week congratulated AMVETS ... Davis of Newark, Del. AMVETS National Commander Larry Via ... the $10,000 sweepstakes grand prize. , AMVETS selected the ... around the country for prizes ranging from $500 to ... May 21 at the AMVETS National Headquarters in Lanham, ...
(Date:5/28/2015)... Ross A. Clevens, MD, FACS, ... Teresa Beard as the new marketing director for Clevens ... oversee all marketing and promotional events for the practice. ... and developing compelling marketing strategies to achieve targeted results. ... served as guest communication manager at the Walt Disney ...
(Date:5/28/2015)... May 28, 2015 As the summer approaches, ... keep cool. It’s important to make safety a top priority, ... some swimming tips. , According to the Centers for Disease ... United States, not including boating incidents. Additionally, the National Safety ... children ages 1 to 4. , Amica is sharing ...
(Date:5/28/2015)... 2015 ISMETT , a leading transplant ... the Sicilian economy by €132.5 million in expenditure in 2013, ... more than €73 million by retaining patients who otherwise would ... new study by the Battelle Memorial Institute. At the same ... and advanced health care management that is transforming Sicily into ...
(Date:5/28/2015)... Altima Technologies, Inc., the maker of popular ... diagramming data center assets and audio-video devices, recently ... , Manufacturer / Device Model, EMC VMAX, ... Cabinet, Middle Atlantic Products RSH Series, Nokia Siemens ... America MM Series, Extron Electronics SW Series, Crestron ...
Breaking Medicine News(10 mins):Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2
... orthopaedic team provides life-changing hip and knee replacements to ... Sept. 8 The Operation Walk Pittsburgh team, consisting ... and Philadelphia recently returned from an extraordinary mission abroad ... 63 successful hip and knee replacements on 50 patients ...
... Sept. 8 Genomma Lab Internacional,S.A.B. de C.V. (BMV: LAB) ... and personal care products companies in Mexico with,expansion into the ... full year of 2009. The Company expects net sales,growth in ... 25%. , The revision of the ...
... , , , ... study conducted at the Temple University School of Medicine and published ... pre-packaged, portion controlled meal plan helped overweight individuals with type 2 ... (a 90-day measure of blood sugar control) by almost a full ...
... , CARMEL, Ind., Sept. 8 Conseco, Inc. ... received the required regulatory approvals for the previously announced transaction ... are coinsuring, with an effective date of January 1, 2009, ... ("Wilton Re"), a Minnesota reinsurance company. , , ...
... Testing for XMRV might help spot more aggressive disease, experts ... study tightens the suspected link between a virus and prostate ... could be an indicator of aggressive tumors that require swift ... moment," stressed Dr. Ila R. Singh, an associate professor of ...
... , , , BEDFORD, Texas, Sept. ... Robert Reiss, the founder and host of one of America,s fastest growing ... the challenges of golf and providing world-class customer service in his upcoming ... Customer Service. Sponsored by The Beryl Institute , the ...
Cached Medicine News:Health News:Operation Walk Pittsburgh Performs Over 63 Free Surgeries in Guatemala 2Health News:Genomma Lab Internacional Revises 2009 Earnings Guidance 2Health News:Newly Published Clinical Study Finds New Commercial Diet Program Superior to Standard Protocol for Diabetes Weight Loss and Blood Sugar Control 2Health News:Newly Published Clinical Study Finds New Commercial Diet Program Superior to Standard Protocol for Diabetes Weight Loss and Blood Sugar Control 3Health News:Newly Published Clinical Study Finds New Commercial Diet Program Superior to Standard Protocol for Diabetes Weight Loss and Blood Sugar Control 4Health News:Newly Published Clinical Study Finds New Commercial Diet Program Superior to Standard Protocol for Diabetes Weight Loss and Blood Sugar Control 5Health News:Newly Published Clinical Study Finds New Commercial Diet Program Superior to Standard Protocol for Diabetes Weight Loss and Blood Sugar Control 6Health News:Conseco Receives Approval to Complete Reinsurance Transaction with Wilton Re 2Health News:Conseco Receives Approval to Complete Reinsurance Transaction with Wilton Re 3Health News:Conseco Receives Approval to Complete Reinsurance Transaction with Wilton Re 4Health News:Conseco Receives Approval to Complete Reinsurance Transaction with Wilton Re 5Health News:Virus May Drive Some Prostate Cancers 2Health News:Virus May Drive Some Prostate Cancers 3Health News:The Beryl Institute Sponsors Free Customer Service Webinar with Robert Reiss 2
Both versions of the UltraSling II provide immobilization for rotator cuff repairs, capusular shifts, Bankhart repairs, glenohumeral dislocations/subluxation and soft tissue repairs/strains....
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... With just a single size, the Sierra ... Its unique design provides the comfort and motion ... confident you will get the right size for ... And, since the single size and compact design ...
Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p...
Medicine Products: